{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:34:38Z","timestamp":1763001278875,"version":"3.45.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007181","name":"VA QUERI","doi-asserted-by":"publisher","award":["I50 HX003266"],"award-info":[{"award-number":["I50 HX003266"]}],"id":[{"id":"10.13039\/100007181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"VA HSR&D","doi-asserted-by":"publisher","award":["1IK2HX003357"],"award-info":[{"award-number":["1IK2HX003357"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014261","name":"National Institute for Health Care Management Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001146","name":"Greenwall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001146","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ahjo.2022.100186","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:53:24Z","timestamp":1658372004000},"page":"100186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction \u226435\u00a0% at least 40\u00a0days after acute myocardial infarction"],"prefix":"10.1016","volume":"19","author":[{"given":"Gregory L.","family":"Judson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth E.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Muniyappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merritt H.","family":"Raitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Tarasovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Whooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket S.","family":"Dhruva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ahjo.2022.100186_bb0005","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100186_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ahjo.2022.100186_bb0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.ahjo.2022.100186_bb0020","first-page":"e272","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ahjo.2022.100186_bb0025","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCULATIONAHA.113.002539","article-title":"Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community","volume":"128","author":"Narayanan","year":"2013","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ahjo.2022.100186_bb0030","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/jama.2015.6409","article-title":"Implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after acute myocardial infarction","volume":"313","author":"Pokorney","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahjo.2022.100186_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCULATIONAHA.116.022359","article-title":"Reassessment of cardiac function and implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after myocardial infarction","volume":"135","author":"Pokorney","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2022.100186_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amjcard.2020.09.056","article-title":"Implantable cardioverter defibrillator utilization and mortality among patients >\/=65 years of age with a low ejection fraction after coronary revascularization","volume":"138","author":"Goldstein","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100186_bb0045","article-title":"Factors influencing utilization of the primary prevention implantable defibrillator","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ahjo.2022.100186_bb0050","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jacc.2015.12.042","article-title":"Predicting persistent left ventricular dysfunction following myocardial infarction: the PREDICTS study","volume":"67","author":"Brooks","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ahjo.2022.100186_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12872-017-0580-8","article-title":"Unlocking echocardiogram measurements for heart disease research through natural language processing","volume":"17","author":"Patterson","year":"2017","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.ahjo.2022.100186_bb0060","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ahjo.2022.100186_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2022.100186_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjcard.2020.08.010","article-title":"Admissions rate and timing of revascularization in the United States in patients with non-ST-elevation myocardial infarction","volume":"134","author":"Case","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ahjo.2022.100186_bb0075","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Writing Committee","year":"2013","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahjo.2022.100186_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000099","article-title":"2020 ACC\/AHA clinical performance and quality measures for adults with heart failure: a report of the American College of Cardiology\/American Heart Association task Force on performance measures","volume":"13","author":"Heidenreich","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"1","key":"10.1016\/j.ahjo.2022.100186_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCHEARTFAILURE.113.000753","article-title":"Clinical reminders to providers of patients with reduced left ventricular ejection fraction increase defibrillator referral: a randomized trial","volume":"7","author":"Gupta","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"2","key":"10.1016\/j.ahjo.2022.100186_bb0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/CIRCOUTCOMES.110.956987","article-title":"Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"4","author":"Gravelin","year":"2011","journal-title":"Circ. Cardiovasc. Qual Outcomes"},{"issue":"4","key":"10.1016\/j.ahjo.2022.100186_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cjco.2019.05.002","article-title":"A population-based study of device eligibility, use, and reasons for nonimplantation in patients at heart function clinics","volume":"1","author":"Bernier","year":"2019","journal-title":"CJC Open"},{"issue":"11","key":"10.1016\/j.ahjo.2022.100186_bb0100","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.hrthm.2014.08.004","article-title":"Rates and reasons for device-based guideline eligibility in patients with heart failure","volume":"11","author":"Lyons","year":"2014","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ahjo.2022.100186_bb0105","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199308263290907","article-title":"Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system","volume":"329","author":"Whittle","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ahjo.2022.100186_bb0110","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1161\/01.STR.0000043672.42831.EB","article-title":"Carotid endarterectomy and race: do clinical indications and patient preferences account for differences?","volume":"33","author":"Oddone","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.ahjo.2022.100186_bb0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ahj.2006.10.032","article-title":"Variation in cardiac procedure use and racial disparity among Veterans Affairs Hospitals","volume":"153","author":"Groeneveld","year":"2007","journal-title":"Am. Heart J."},{"issue":"13","key":"10.1016\/j.ahjo.2022.100186_bb0120","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/jama.298.13.1525","article-title":"Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure","volume":"298","author":"Hernandez","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ahjo.2022.100186_bb0125","doi-asserted-by":"crossref","first-page":"167.e17","DOI":"10.1016\/j.amjmed.2005.08.021","article-title":"Disparities in the use of primary prevention and defibrillator therapy among blacks and women","volume":"119","author":"Gauri","year":"2006","journal-title":"Am. J. Med."},{"issue":"16","key":"10.1016\/j.ahjo.2022.100186_bb0130","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/CIRCULATIONAHA.114.015124","article-title":"Association of race with mortality and cardiovascular events in a large cohort of US veterans","volume":"132","author":"Kovesdy","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahjo.2022.100186_bb0135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jama.285.3.297","article-title":"Racial differences in mortality among men hospitalized in the Veterans Affairs health care system","volume":"285","author":"Jha","year":"2001","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ahjo.2022.100186_bb0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMms2025396","article-title":"How structural racism works - racist policies as a root cause of U.S. racial health inequities","volume":"384","author":"Bailey","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ahjo.2022.100186_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamainternmed.2017.8462","article-title":"Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease","volume":"178","author":"Bansal","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"23","key":"10.1016\/j.ahjo.2022.100186_bb0150","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahjo.2022.100186_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCOUTCOMES.115.002053","article-title":"Geriatric conditions in patients undergoing defibrillator implantation for prevention of sudden cardiac death: prevalence and impact on mortality","volume":"9","author":"Green","year":"2016","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"15","key":"10.1016\/j.ahjo.2022.100186_bb0160","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ahjo.2022.100186_bb0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Writing","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ahjo.2022.100186_bb0170","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.20969","article-title":"Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare part D program","volume":"3","author":"Luo","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.ahjo.2022.100186_bb0175","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2016.12.005","article-title":"Trends in U.S. cardiovascular care: 2016 report from 4 ACC National Cardiovascular Data Registries","volume":"69","author":"Masoudi","year":"2017","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602222001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:28:44Z","timestamp":1763000924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602222001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":35,"alternative-id":["S2666602222001033"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100186","relation":{},"ISSN":["2666-6022"],"issn-type":[{"type":"print","value":"2666-6022"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction \u226435\u00a0% at least 40\u00a0days after acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2022.100186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100186"}}